[{"address1": "9920 Pacific Heights Boulevard", "address2": "Suite 350", "city": "San Diego", "state": "CA", "zip": "92121", "country": "United States", "phone": "858 704 4660", "website": "https://www.vikingtherapeutics.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TR\u00df), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. It also develops VK5211, an orally available non-steroidal selective androgen receptor modulator that is in Phase II clinical trials for the treatment of patients recovering from non-elective hip fracture surgery; VK0612, an orally available Phase IIb-ready drug candidate for type 2 diabetes; VK2735, a novel dual agonist of the glucagon-like peptide, which is in Phase 1 SAD/MAD clinical trial, and VK0214, an orally available tissue and receptor-subtype selective agonist of the TR\u00df for X-linked adrenoleukodystrophy. The company was incorporated in 2012 and is headquartered in San Diego, California.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Brian  Lian Ph.D.", "age": 58, "title": "President, CEO & Director", "yearBorn": 1966, "fiscalYear": 2023, "totalPay": 987100, "exercisedValue": 0, "unexercisedValue": 13998124}, {"maxAge": 1, "name": "Mr. Gregory S. Zante CPA, CPA", "age": 53, "title": "Chief Financial Officer", "yearBorn": 1971, "fiscalYear": 2023, "totalPay": 655000, "exercisedValue": 0, "unexercisedValue": 59203}, {"maxAge": 1, "name": "Ms. Marianne  Mancini", "age": 59, "title": "Chief Operating Officer", "yearBorn": 1965, "fiscalYear": 2023, "totalPay": 670000, "exercisedValue": 0, "unexercisedValue": 2005070}, {"maxAge": 1, "name": "Mr. Michael  Morneau", "age": 59, "title": "Vice President of Finance & Administration", "yearBorn": 1965, "fiscalYear": 2023, "totalPay": 375333, "exercisedValue": 0, "unexercisedValue": 490518}, {"maxAge": 1, "name": "Dr. Geoffrey E. Barker Ph.D.", "title": "Chief Development Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 8, "compensationRisk": 8, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1738368000, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 31.63, "open": 31.83, "dayLow": 31.5, "dayHigh": 36.39, "regularMarketPreviousClose": 31.63, "regularMarketOpen": 31.83, "regularMarketDayLow": 31.5, "regularMarketDayHigh": 36.39, "payoutRatio": 0.0, "beta": 0.893, "forwardPE": -22.569538, "volume": 14750454, "regularMarketVolume": 14750454, "averageVolume": 3835042, "averageVolume10days": 4976830, "averageDailyVolume10Day": 4976830, "bid": 32.43, "ask": 35.63, "bidSize": 1, "askSize": 1, "marketCap": 3802442240, "fiftyTwoWeekLow": 28.64, "fiftyTwoWeekHigh": 99.41, "fiftyDayAverage": 37.732, "twoHundredDayAverage": 54.7195, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 2627577344, "profitMargins": 0.0, "floatShares": 109091008, "sharesOutstanding": 111574000, "sharesShort": 23930853, "sharesShortPriorMonth": 19468391, "sharesShortPreviousMonthDate": 1735603200, "dateShortInterest": 1738281600, "sharesPercentSharesOut": 0.21450001, "heldPercentInsiders": 0.0327, "heldPercentInstitutions": 0.75543, "shortRatio": 6.84, "shortPercentOfFloat": 0.288, "impliedSharesOutstanding": 111574000, "bookValue": 7.89, "priceToBook": 4.3193917, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -109963000, "trailingEps": -1.01, "forwardEps": -1.51, "52WeekChange": -0.15473008, "SandP52WeekChange": 0.2021538, "quoteType": "EQUITY", "currentPrice": 34.08, "targetHighPrice": 164.0, "targetLowPrice": 38.0, "targetMeanPrice": 99.29412, "targetMedianPrice": 102.0, "recommendationMean": 1.52941, "recommendationKey": "buy", "numberOfAnalystOpinions": 17, "totalCash": 902611968, "totalCashPerShare": 8.09, "totalDebt": 1119000, "quickRatio": 32.926, "currentRatio": 33.094, "debtToEquity": 0.127, "returnOnAssets": -0.14774999, "returnOnEquity": -0.17899, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "VKTX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "messageBoardId": "finmb_246791410", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 7.74582, "regularMarketPrice": 34.08, "shortName": "Viking Therapeutics, Inc.", "longName": "Viking Therapeutics, Inc.", "marketState": "REGULAR", "regularMarketTime": 1740171310, "exchange": "NCM", "averageAnalystRating": "1.5 - Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1430227800000, "regularMarketChange": 2.4500027, "regularMarketDayRange": "31.5 - 36.39", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 3835042, "fiftyTwoWeekLowChange": 5.4400024, "fiftyTwoWeekLowChangePercent": 0.18994422, "fiftyTwoWeekRange": "28.64 - 99.41", "fiftyTwoWeekHighChange": -65.33, "fiftyTwoWeekHighChangePercent": -0.6571773, "fiftyTwoWeekChangePercent": -15.473008, "earningsTimestamp": 1738789515, "earningsTimestampStart": 1745319540, "earningsTimestampEnd": 1745841600, "earningsCallTimestampStart": 1738791000, "earningsCallTimestampEnd": 1738791000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.01, "epsForward": -1.51, "epsCurrentYear": -1.55224, "priceEpsCurrentYear": -21.955368, "fiftyDayAverageChange": -3.6519966, "fiftyDayAverageChangePercent": -0.09678779, "twoHundredDayAverageChange": -20.6395, "twoHundredDayAverageChangePercent": -0.37718728, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "displayName": "Viking Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-02-21"}]